Cohort1: dose level 1_ATLCAR.CD30.CCR4 cells
|
Administration route |
intravenous infusion |
Dosage |
2E7 cells/m^2 |
Pts |
59 |
Age |
Adult, Older_Adult |
Lymph depletion |
Yes |
|
Cohort2: dose level 1_ATLCAR.CD30.CCR4 cells_ATLCAR.CD30 cells
|
Administration route |
intravenous infusion |
Dosage |
2E7 cells/m^2, 1E8 cells/m^2 |
Pts |
59 |
Age |
Adult, Older_Adult |
Lymph depletion |
Yes |
|
Cohort3: dose level 2_ATLCAR.CD30.CCR4 cells
|
Administration route |
intravenous infusion |
Dosage |
5E7 cells/m^2 |
Pts |
59 |
Age |
Adult, Older_Adult |
Lymph depletion |
Yes |
|
Cohort4: dose level 2_ATLCAR.CD30.CCR4 cells_ATLCAR.CD30 cells
|
Administration route |
intravenous infusion |
Dosage |
5E7 cells/m^2, 1E8 cells/m^2 |
Pts |
59 |
Age |
Adult, Older_Adult |
Lymph depletion |
Yes |
|
Cohort5: dose level 3_ATLCAR.CD30.CCR4 cells
|
Administration route |
intravenous infusion |
Dosage |
1E8 cells/m^2 |
Pts |
59 |
Age |
Adult, Older_Adult |
Lymph depletion |
Yes |
|
Cohort6: dose level 3_ATLCAR.CD30.CCR4 cells_ATLCAR.CD30 cells
|
Administration route |
intravenous infusion |
Dosage |
1E8 cells/m^2, 1E8 cells/m^2 |
Pts |
59 |
Age |
Adult, Older_Adult |
Lymph depletion |
Yes |
|